Lahey Clinic

lahey.org

Total trials

60

Active

8

Phase 3

3

Total enrollment

243,293

Read this sponsor's pipeline like an analyst.

Generate a written report: strategic focus, priority programs, pipeline shape, recent terminations and momentum, and the trials worth watching in the next 12 months.

~15-30 sec · cached for 24h

Pipeline matrix

Showing 6 of 6 active programs · click any cell for trials

InterventionEarly Phase 1Phase 1Phase 2Phase 3Phase 4N/ATotal
Long-Acting Local Anesthesia1
Regional Anesthesia1
Methadone1
ketamine1
Hydromorphone1
fentanyl1

Next readouts

  • 2026-07-01
  • 2026-09-01

Top conditions

  • Hepatocellular Carcinoma3
  • Progressive Supranuclear Palsy2
  • Interstitial Lung Disease2
  • HCC2
  • Pain2
  • Cervical Spondylosis With Myelopathy2
  • Degenerative Spondylolisthesis2
  • Lumbar Spondylolisthesis2

Frequently asked questions about Lahey Clinic

How many clinical trials does Lahey Clinic have on ClinicalTrials.gov?
Lahey Clinic is listed as the lead sponsor on 60 clinical trials in ClinicalTrials.gov, 8 of which are currently active (recruiting, enrolling, or ongoing).
How many of Lahey Clinic's trials are in Phase 3?
3 of Lahey Clinic's trials are in Phase 3, spread across 6 active drug programs.
What therapeutic areas does Lahey Clinic focus on?
Lahey Clinic's most-studied conditions on ClinicalTrials.gov are Hepatocellular Carcinoma, Progressive Supranuclear Palsy, Interstitial Lung Disease, HCC, Pain.
When are Lahey Clinic's next clinical trial readouts?
Lahey Clinic has 2 upcoming primary-completion readouts tracked here; the soonest is “Reducing Pain With Methadone and Ketamine in Liver Transplant”, expected around 2026-07-01.